Register now and you will receive a link to view the video of the event.
Recorded on November 16, 2021 From 1:00 – 2:15 pm EST
Join our panel of experts for presentations and discussion on Real World Evidence In IBD including: pharmacokinetic modelling In IBD therapeutics, IBD drug development & comparative effectiveness research
Our expert panel will provide an overview of the different types of Real World Evidence (RWE), a summary of the FDA position and an outline of opportunities and challenges. Presentations will outline how RWE can be used to inform pharmacokinetic modelling for IBD therapeutics, describe the methodologies to use RWE to inform comparative effectiveness research in IBD, and describe how network meta-analysis can be used to inform drug positioning in IBD.
Presentations will include:
Dr. Jairath oversees the global Medical R&D initiatives and services… Read More
Dr. Jessica Allegretti is a gastroenterologist at Brigham and Women’s Hospital in Boston, MA… Read More
Martin leads and oversees the growth, scientific service offerings, and consulting of the newly formed… Read More
Dr. Niels Vande Casteele oversees and directs all business and scientific aspects at AcelaBio. He sets the… Read More
Dr. Michael Kappelman, MD, MPH is a Professor of Pediatrics and Epidemiology at the University of North Carolina at Chapel Hill… Read More